TransCode Therapeutics Inc.
RNAZ | NASDAQ
$1.76
+$0.11 (+6.67%)
At close: Sep 21, 2026, 4:00 PM ET
$1.76
$0 (0.00%)
Pre-market:
Sep 22, 2026, 4:44 AM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 28.72K | 28.72K | 4.78K | 4.78K | 127.52K | 127.52K | 127.52K | 267.69K | 278.96K | 416.55K | 516.75K | 406.08K | 292.1K | 177.2K | 98.61K | 98.09K | 80.82K | 62.82K | 42.47K | 13.48K | 5.95K | 1.26K |
Gross Profit | -28.72K | -28.72K | -4.78K | -4.78K | -127.52K | -127.52K | -127.52K | -267.69K | -278.96K | -416.55K | -516.75K | -406.08K | -292.1K | -177.2K | -98.61K | -98.09K | -80.82K | -62.82K | -42.47K | -13.48K | -5.95K | -1.26K |
Operating Income | -27.92M | -32.14M | -27.98M | -17.05M | -14.65M | -15.54M | -15.66M | -14.63M | -17.79M | -17.81M | -19.42M | -20.89M | -20.51M | -20.09M | -18.67M | -16.12M | -13.53M | -9.18M | -6.15M | -3.54M | -1.42M | -1.16M |
Interest Income | 52.34M | 170.94K | 79.2K | 600 | 632 | 662 | 684 | 662 | 614 | 682 | 5.28K | 14.78K | 23.65K | 24.74K | 20.41K | 11.28K | 2.42K | 1.09K | 664 | 176 | 63 | 119 |
Pretax Income | -6.79B | -39.9M | -34.44M | -27.13M | -24.6M | -25.51M | -16.75M | -14.93M | -17.91M | -17.06M | -18.55M | -19.59M | -18.58M | -18.91M | -17.56M | -15.23M | -13.27M | -5.83M | -6.84M | -4.85M | -3.89M | -6.79M |
Net Income | -6.9B | -40.36M | -34.66M | -27.13M | -24.6M | -25.51M | -16.75M | -14.93M | -17.91M | -17.06M | -18.55M | -19.59M | -18.58M | -18.91M | -17.56M | -15.23M | -13.27M | -5.83M | -6.84M | -4.85M | -3.89M | -6.79M |
Selling & General & Admin | 4.76B | 2.23B | 5.77M | 5.46M | 4.89M | 5.26M | 5.84M | 4.94M | 5.96M | 5.96M | 6.64M | 8.92M | 8.99M | 9.02M | 8.39M | 7.22M | 6.67M | 4.74M | 3.36M | 1.91M | 737.52K | 615.04K |
Research & Development | 8.81B | 5.12B | 13.42M | 11.58M | 9.64M | 10.15M | 9.69M | 9.42M | 11.55M | 11.43M | 12.26M | 11.56M | 11.23M | 10.89M | 10.18M | 8.81M | 6.78M | 4.37M | 2.75M | 1.62M | 681.27K | 544.52K |
Other Expenses | -6.75B | -7.31B | 8.79M | 0 | 0 | n/a | 0 | 0 | 0 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 6.82B | 32.11M | 27.98M | 17.04M | 14.52M | 15.42M | 15.53M | 14.36M | 17.51M | 17.39M | 18.9M | 20.48M | 20.22M | 19.91M | 18.57M | 16.03M | 13.45M | 9.12M | 6.11M | 3.53M | 1.42M | 1.16M |
Interest Expense | 6.5K | 6.5K | 6.62K | 7.91K | 12.74K | 17.22K | 26.81K | 80.88K | 87.37K | 90.73K | 94.45K | 38.55K | 21.27K | 13.43K | n/a | n/a | 333 | 42.3K | 95.07K | 148.93K | 428.88K | 422.56K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 27.92M | 32.14M | 27.98M | 17.05M | 14.65M | 15.54M | 15.66M | 14.63M | 17.79M | 17.81M | 19.42M | 20.89M | 20.51M | 20.09M | 18.67M | 16.12M | 13.53M | 9.18M | 6.15M | 3.54M | 1.42M | 1.16M |
Income Tax Expense | 157.38K | 457.38K | 226.07K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 957.19K | 916.97K | 916.97K | 833.68K | 833.65K | 172.26K | 356.12K | 356.12K | 213.67K | 213.67K | 213.67K | 109.41K | 30.49K | 30.49K | 30.49K | 16.22K | 16.22K | 16.22K | 16.22K | 14.41K | 14.96K | 14.95K |
Shares Outstanding (Diluted) | 957.19K | 916.97K | 916.97K | 833.68K | 833.65K | 172.26K | 356.12K | 356.12K | 213.67K | 213.67K | 213.67K | 109.41K | 30.49K | 30.49K | 30.49K | 16.22K | 16.22K | 16.22K | 16.22K | 14.41K | 14.96K | 14.95K |
EPS (Basic) | -7.22K | -48.65 | -97.65 | -97.84 | -98.54 | -117.83 | -69 | -813.55 | -855.47 | -973.43 | -1.21K | -38.28K | -38.49K | -38.64K | -38.6K | -19.17K | -19.07K | -18.6K | -18.68K | -3.62K | -3.64K | -3.84K |
EPS (Diluted) | -7.22K | -48.65 | -97.65 | -97.84 | -98.54 | -117.83 | -69 | -813.55 | -855.47 | -973.43 | -1.21K | -38.28K | -38.49K | -38.64K | -38.6K | -19.02K | -18.92K | -18.45K | -18.53K | -3.62K | -3.64K | -3.84K |
EBITDA | -35.55M | -39.81M | -34.31M | -26.93M | -24.27M | -25.05M | -16.19M | -14.29M | -17.27M | -16.43M | -17.97M | -19.19M | -18.29M | -18.73M | -17.47M | -15.13M | -13.19M | -5.72M | -6.71M | -4.68M | -3.46M | -6.27M |
EBIT | -35.62M | -39.9M | -34.43M | -27.13M | -24.59M | -25.5M | -16.73M | -14.85M | -17.84M | -16.99M | -18.49M | -19.59M | -18.58M | -18.91M | -17.56M | -15.23M | -13.27M | -5.79M | -6.75M | -4.7M | -3.46M | -6.37M |
Depreciation & Amortization | 73.5K | 86.94K | 114.18K | 192.25K | 314.99K | 444.38K | 534.86K | 552.18K | 563.44K | 558.19K | 516.75K | 406.08K | 292.1K | 177.2K | 98.61K | 98.09K | 80.82K | 62.82K | 42.47K | 13.48K | 5.95K | 92.86K |
Add to Watchlist
Select watchlists to add or remove RNAZ